Simulations Plus to Present at the 21st Annual Needham Growth Conference

Marketing News – MarketingTools365 – Mktg News – Marketing Tools 365 – //// Business Marketing news and Mktg News : Simulations Plus to Present at the 21st Annual Needham Growth Conference :

LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq:SLP), the premier provider of simulation
and modeling software and consulting services for pharmaceutical
discovery and development, today announced that chief executive officer
Shawn O’Connor will present at the 21st Annual Needham Growth
Conference in New York City on Wednesday, January 16, 2019, at 8:40 a.m.
ET (5:40 a.m. PT). In addition to his presentation, Mr. O’Connor will
host one-on-one meetings throughout the day at the conference which will
be held at the Lotte New York Palace Hotel.

A live webcast of the presentation will be accessible from the Events
section of the Company’s website (
The webcast will be archived for a period of 90 days. For more
information about the conference or to schedule a one-on-one meeting
with Mr. O’Connor, please contact Hayden IR at

About Simulations Plus, Inc.

Simulations Plus, Inc. is a premier developer of drug discovery and
development software as well as a leading provider of both preclinical
and clinical pharmacometric consulting
for regulatory submissions and quantitative
systems pharmacology models
for drug-induced
liver injury
, drug-induced
kidney injury
, and nonalcoholic
fatty liver disease
. The company is a global leader focused on
improving the ways scientists use knowledge and data to predict the
properties and outcomes of pharmaceutical, biotechnology, and chemical
agents. Our software is licensed to and used in the conduct of drug
research by major pharmaceutical, biotechnology, chemical, and consumer
goods companies and regulatory agencies worldwide. Our innovations in
integrating new and existing science in medicinal chemistry,
computational chemistry, pharmaceutical science, biology, and physiology
into our software have made us the leading software provider for
physiologically based pharmacokinetic modeling and simulation. For more
information, visit our website at

Follow us on Twitter
| LinkedIn


Simulations Plus Investor Relations
Renee Bouche

Hayden IR
Mr. Cameron Donahue

. From Business Wire – Marketingtools365(COMM) – ATOM Source : Simulations Plus to Present at the 21st Annual Needham Growth Conference –